KATHRYN SCHLAPPI: Open Payments
NPI 1295428779 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 72 payments from 16 companies in 2025. Trend: 2023 $397 · 2024 $1,015 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $547 |
| Collegium Pharmaceutical, Inc. | 5 | $86 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Ardelyx, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 2 | $30 |
Products named: UBRELVY, QULIPTA, VRAYLAR, Belbuca, Ozempic, CAPLYTA, IBSRELA, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
